Authors

Sabrina Mokinaro, National Research Council, Institute of Clinical Physiology (CNR-IFC), Pisa, Italy
Julian Vincente, European Monitoring Centre for Drugs and Drug Addiction (EMCDDA), Lisbon, Portugal
Elisa Benedetti, National Research Council, Institute of Clinical Physiology (CNR-IFC), Pisa, Italy
Sonia Cerrai, National Research Council, Institute of Clinical Physiology (CNR-IFC), Pisa, Italy
Emanuala Colasante, National Research Council, Institute of Clinical Physiology (CNR-IFC), Pisa, Italy
Sharon Arpa, Aġenzija Sedqa (National Agency against Drug and Alcohol Abuse and Compulsive Gambling), Foundation for Social Welfare Services, Santa Venera, Malta
Pavla Chomynova, Czech National Monitoring Centre for Drugs and Addictions, Office of the Government of the Czech Republic (NMC); National Institute of Mental Health (NIMH), Prague, Czechia
Ludwig Kraus, IFT Institut für Therapieforschung, Munich, Germany
Karin Monshouwer, Trimbos Institute, Utrecht, the Netherlands
Stanislas Spika, French Monitoring Centre for Drugs and Drug Addiction (OFDT), Paris, France
Arsaell Mar Arnarsson, University of Iceland, Akureyri, Iceland
Olga Balakireva, Department for Monitoring Research on Socio-economic Transformations, Institute for Economics and Forecasting, National Academy of Sciences of Ukraine (IEF NASU), Kiev, Ukraine
Begona Brime Beteta
Elin Kristin Bye
Anina Chileva
Luke Clancy, Tobacco Free Research Institute, DublinFollow
Zamira Hyseni Duraku, u Faculty of Philosophy and Department of Psychology, University of Prishtina ‘Hasan Prishtina’, Prishtina, Kosovo
Tatijana Durisic, Public Health Institute of Montenegro, Podgorica, Montenegro
Olga Ekholm, National Institute of Public Health, University of Southern Denmark, Copenhagen, Denmark
Zsuzsanna Elekes, Institute of Sociology and Social Policy, Corvinus University of Budapest, Budapest, Hungary
Silvia Florescu, National School of Public Health, Management and Professional Development, Bucharest, Romania
Biljana Kilibarda, Institute of Public Health of Serbia (IPHS), Belgrade, Serbia
Anna Kokkevi, Athens University Mental Health, Neurosciences and Precision Medicine Research Institute (UMHRI), Athens, Greece
Elsa Lavado, General-Directorate for Intervention on Addictive Behaviours and Dependencies (SICAD-Ministry of Health), Lisbon, Portugal
Tanja Urdih Lazar, Clinical Institute of Occupational, Traffic and Sports Medicine, University Medical Centre Ljubljana, Ljubljana, Slovenia
Martina Markelic, Croatian Institute of Public Health (CIPH), Zagreb, Croatia
Alojz Nociar, Croatian Institute of Public Health (CIPH), Zagreb, Croatia
Silvana Oncheva, Institute of Public Health, Skopje, North Macedonia
Kirsimarja Raitasalo, Finnish Institute for Health and Welfare, Helsinki, Finland
Ludmilla Rupsience, Klaipėda University, Klaipėda, Lithuania
Janusz Sieroslawski, Institute of Psychiatry and Neurology (IPiN), Warsaw, Poland
Julian Strizek, Gesundheit Österreich GmbH, Vienna, Austria
Lela Sturua, National Center for Disease Control and Public Health, Tiblisi, Georgia
Johan Svensson, Swedish Council for Information on Alcohol and Other Drugs (CAN), Stockholm, Sweden
Diana Vanaga, Stockholm, Sweden Diāna Vanaga Centre for Disease Prevention and Control, Riga, Latvia
Kyriakos Veresies, Center for Education about Drugs and Treatment of Drug Addicted Persons, Nicosia, Cyprus
Sigrid Vorobjov, National Institute for Health Development, Tallinn, Estonia
Pai Weihe, Department of Occupational Medicine and Public Health, Tórshavn, Faroe Islands
Rodolfo Cotichini, National Research Council, Institute of Clinical Physiology (CNR-IFC), Pisa, Italy
Loredana Fortunato, National Research Council, Institute of Clinical Physiology (CNR-IFC), Pisa, Italy
Katenna Skarupova, European Monitoring Centre for Drugs and Drug Addiction (EMCDDA), Lisbon, Portugal

Document Type

Report

Rights

Available under a Creative Commons Attribution Non-Commercial Share Alike 4.0 International Licence

Disciplines

Bioinformatics

Abstract

The main purpose of the European School Survey Project on Alcohol and Other Drugs (ESPAD) is to collect comparable data on substance use and other forms of risk behaviour among 15- to 16-year-old students in order to monitor trends within, as well as between, countries. Between 1995 and 2019, seven waves of data collection were conducted across 49 European countries. This report presents selected key results. The full set of data on which the current report is based, including all of the standard tables, is available online (http://www.espad.org). All tables can be downloaded in Excel format and used for further analysis

DOI

https://doi.org/10.2810/877033


Included in

Diseases Commons

Share

COinS